Discontinued — last reported Q4 '25
Southern Company Business Sale Proceeds increased by 460.7% to $757.00M in Q4 2021 compared to the prior quarter.
An increase signals portfolio optimization or a strategic pivot, while a lack of proceeds suggests a stable, long-term asset base.
This metric represents the cash inflows received from the divestiture or sale of business segments, product lines, or su...
Occurs sporadically; peers often divest legacy segments to focus on high-margin innovation areas like continuous glucose monitoring or diagnostics.
cf_proceeds_from_sale_of_business| Q2 '21 | Q3 '21 | Q4 '21 | |
|---|---|---|---|
| Value | $5.00M | $135.00M | $757.00M |
| QoQ Change | — | >999% | +460.7% |